Acute flaccid paralysis as initial symptom in 4 patients with novel E1alpha mutations of the pyruvate dehydrogenase

H M Strassburg1, J Koch, J Mayr

  • 1University Children's Hospital Würzburg, Germany.

Neuropediatrics
|September 13, 2006
PubMed

Insights

Pyruvate dehydrogenase deficiency can mimic Guillain-Barré syndrome in infants. Early evaluation for this mitochondrial disorder is crucial, even with initial normal findings.

Area of Science:

  • Biochemistry
  • Genetics
  • Neurology

Background:

  • Infantile onset of acute flaccid tetraparesis and areflexia can resemble Guillain-Barré syndrome (GBS).
  • Distinguishing GBS from other neurological conditions with similar presentations is critical for appropriate management.

Observation:

  • Four boys from three families presented with recurrent episodes of flaccid tetraparesis and areflexia.
  • Elevated serum and cerebrospinal fluid (CSF) lactate levels were observed, with normal CSF protein.
  • Brain MRI revealed basal ganglia hyperintensities in some patients, while motor nerve conduction velocities remained normal.

Findings:

  • Muscle tissue analysis identified pyruvate dehydrogenase (PDH) deficiency in two patients.
  • Genetic analysis uncovered three novel mutations in the X-chromosomal E1alpha subunit of PDH.
  • These mutations were located in phylogenetically conserved regions of the PDH protein.

Implications:

  • Children presenting with atypical GBS symptoms warrant investigation for mitochondrial disorders, specifically PDH deficiency.
  • This highlights the importance of considering metabolic causes in unexplained neurological presentations in infancy.
  • Timely diagnosis of PDH deficiency enables appropriate supportive care and genetic counseling.

Related Concept Videos

Botulism01:22

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...